Clinical Trial

The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Trial Details
NCT Number NCT07144592
Lead Sponsor Muş Alparslan University
Conditions SCHIZOPHRENIA 1 (Disorder), Psychosocial Adaptation, Treatment Adherence
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2025-02-25 (estimated)
Study Completion 2025-10-25 (estimated)
Updated on ClinicalTrials.gov 2025-08-27